| Affiliation: | 1. Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas;2. Division of Hematology and Oncology, University of California San Diego Moores Cancer Center, San Diego, California;3. Thomas Jefferson University, Philadelphia, Pennsylvania;4. Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas;5. Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas;6. Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, Texas;7. Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas;8. Developmental Therapeutics, Lurie Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois Division of Hematology Oncology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois;9. California Pacific Medical Center Research Institute, San Francisco, California;10. Sarah Cannon Research Institute at Health ONE, Denver, Colorado |
